Novartis Entresto lawsuit underlines growing importance of cocrystals for patent strategy
US university litigation seeks damages and ongoing royalties over blockbuster heart failure drug which generated $2.22 billion in 2H 2022
To read more
Register for limited access
Register to receive our newsletter and gain limited access to subscriber content.
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the IAM experts.